ENTITY

Elpiscience Biopharmaceuticals (ELPI HK)

1
Analysis
Health CareChina

22 Jul 2024 08:55

Pre-IPO Elpiscience Biopharmaceuticals - Will Investors Still Buy in These Stories?

​Elpiscience's strong capital operation capabilities are no longer enough as investors shift focus to cash flow and drug sales revenue. We have...

Logo
263 Views
Share
No more insights
x